These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 1301342

  • 21. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 22. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
    Lingnau A, Miller K, Steiner U, Jentzmik F, Weikert S, Schostak M.
    Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
    [Abstract] [Full Text] [Related]

  • 23. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer.
    Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM.
    Clin Cancer Res; 2008 Jan 01; 14(1):224-9. PubMed ID: 18172274
    [Abstract] [Full Text] [Related]

  • 24. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Jalón Monzón A, Martínez Gómez FJ, Sánchez Trilla A, Regadera Sejas J.
    Arch Esp Urol; 2007 Jan 01; 60(1):36-43. PubMed ID: 17408170
    [Abstract] [Full Text] [Related]

  • 25. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
    Han RF, Pan JG.
    Urology; 2006 Jun 01; 67(6):1216-23. PubMed ID: 16765182
    [Abstract] [Full Text] [Related]

  • 26. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP.
    Eur Urol; 2007 Oct 01; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Serial urinary IL-2, IL-6, IL-8, TNFalpha, UBC, CYFRA 21-1 and NMP22 during follow-up of patients with bladder cancer receiving intravesical BCG.
    Sanchez-Carbayo M, Urrutia M, Romani R, Herrero M, Gonzalez de Buitrago JM, Navajo JA.
    Anticancer Res; 2001 Oct 01; 21(4B):3041-7. PubMed ID: 11712808
    [Abstract] [Full Text] [Related]

  • 30. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT, Yildirim U, Zorlu F, Ozen H.
    J Urol; 2006 May 01; 175(5):1641-4. PubMed ID: 16600720
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences.
    Böhle A, Busemann E, Gerdes J, Ulmer AJ, Flad HD, Jocham D.
    Dev Biol Stand; 1992 May 01; 77():199-209. PubMed ID: 1426663
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [The preventive recurrent results of postoperative intravesical instillation therapy in bladder cancer].
    Zhang S, Li H, Cheng H.
    Zhonghua Wai Ke Za Zhi; 1995 May 01; 33(5):304-6. PubMed ID: 7587700
    [Abstract] [Full Text] [Related]

  • 35. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
    Rivera P, Caffarena E, Cornejo H, Del Pino M, Fonerón A, Haemmersli J, Sepúlveda M, Ubilla A.
    Actas Urol Esp; 1993 Apr 01; 17(4):243-6. PubMed ID: 8342414
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL.
    Zhonghua Wai Ke Za Zhi; 1989 Nov 01; 27(11):654-5, 700. PubMed ID: 2517250
    [Abstract] [Full Text] [Related]

  • 38. [Long-term results of intravesical N-CWS instillation to prevent recurrence after surgery for bladder cancer].
    Chen S, Lin Z, Xu E.
    Zhonghua Zhong Liu Za Zhi; 1997 May 01; 19(3):228-30. PubMed ID: 10920905
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
    Huncharek M, Kupelnick B.
    Am J Clin Oncol; 2003 Aug 01; 26(4):402-7. PubMed ID: 12902895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.